Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction

PLoS Pathogens

Volumn 7, Issue 6, 2011, Pages

  van Riel, Debby ^a   Leijten, Lonneke M E ^a   van der Eerden, Menno ^a   Hoogsteden, Henk C ^a   Boven, Leonie A ^a,b   Lambrecht, Bart N ^c   Osterhaus, Albert D M E ^a   Kuiken, Thijs ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Meander MC ^*  (Netherlands)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COMPARATIVE STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; MONOCYTE MACROPHAGE PRECURSOR CELL; NONHUMAN; PHENOTYPE; VIROGENESIS; VIRUS VIRULENCE; BIOSYNTHESIS; CELL CULTURE; INFLUENZA VIRUS A H1N1; PATHOGENICITY; VIROLOGY; VIRUS REPLICATION;

AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

CELLS, CULTURED; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; MACROPHAGES, ALVEOLAR; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 79959824589     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002099     Document Type: Article

References (37)

1. Kuiken T, Taubenberger JK, (2008) Pathology of human influenza revisited. Vaccine 26 D59-66 (Suppl 4): D59-D66.
2. Korteweg C, Gu J, (2008) Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 172: 1155-1170.
3. de Jong MD, (2008) H5N1 transmission and disease: observations from the frontlines. Pediatr Infect Dis J 27: S54-S56.
4. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, et al. (2007) Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 171: 1215-1223.
5. Chutinimitkul S, Herfst S, Steel J, Lowen AC, Ye J, et al. (2010) Virulence-associated substitution D222G in hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol 84: 11802-11813.
6. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, et al. (2006) H5N1 Virus Attachment to Lower Respiratory Tract. Science 312: 399.
7. Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K, et al. (2005) Influenza A H5N1 replication sites in humans. Emerg Infect Dis 11: 1036-1041.
8. Gu J, Xie Z, Gao Z, Liu J, Korteweg C, et al. (2007) H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370: 1137-1145.
9. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, et al. (2006) Avian flu: influenza virus receptors in the human airway. Nature 440: 435-436.
10. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, et al. (2007) Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 13: 147-149.
11. Gordon SB, Read RC, (2002) Macrophage defences against respiratory tract infections. Br Med Bull 61: 45-61.
12. Lambrecht BN, (2006) Alveolar macrophage in the driver's seat. Immunity 24: 366-368.
13. Orgeig S, Hiemstra PS, Veldhuizen EJ, Casals C, Clark HW, et al. (2010) Recent advances in alveolar biology: Evolution and function of alveolar proteins. Respir Physiol Neurobiol 83: 792-807.
14. Stein M, Keshav S, Harris N, Gordon S, (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292.
15. Goerdt S, Orfanos CE, (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137-142.
16. Gordon S, Martinez FO, (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
17. Martinez FO, Sica A, Mantovani A, Locati M, (2008) Macrophage activation and polarization. Front Biosci 13: 453-61.
18. Holt PG, (1986) Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages. Clin Exp Immunol 63: 261-270.
19. Hashimoto Y, Moki T, Takizawa T, Shiratsuchi A, Nakanishi Y, (2007) Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol 178: 2448-2457.
20. Watanabe Y, Hashimoto Y, Shiratsuchi A, Takizawa T, Nakanishi Y, (2005) Augmentation of fatality of influenza in mice by inhibition of phagocytosis. Biochem Biophys Res Commun 337: 881-886.
21. Thepen T, Van Rooijen N, Kraal G, (1989) Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 170: 499-509.
22. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, et al. (2005) Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79: 14933-14944.
23. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360: 1831-1837.
24. Lee SM, Gardy JL, Cheung CY, Cheung TK, Hui KP, et al. (2009) Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One 4: e8072.
25. Lee SM, Cheung CY, Nicholls JM, Hui KP, Leung CY, et al. (2008) Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis 198: 525-535.
26. Ettensohn DB, Roberts NJ Jr, (1984) Influenza virus infection of human alveolar and blood-derived macrophages: differences in accessory cell function and interferon production. J Infect Dis 149: 942-949.
27. Rodgers BC, Mims CA, (1982) Influenza virus replication in human alveolar macrophages. J Med Virol 9: 177-184.
28. Akagawa KS, Komuro I, Kanazawa H, Yamazaki T, Mochida K, et al. (2006) Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages. Respirology 11 Suppl pp. S32-S36.
29. Bogdan C, Paik J, Vodovotz Y, Nathan C, (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 267: 23301-23308.
30. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, et al. (2009) Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A 106: 14978-14983.
31. Headley AS, Tolley E, Meduri GU, (1997) Infections and the inflammatory response in acute respiratory distress syndrome. Chest 111: 1306-1321.
32. Guth AM, Janssen WJ, Bosio CM, Crouch EC, Henson PM, et al. (2009) Lung environment determines unique phenotype of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 296: L936-L946.
33. Akagawa KS, (2002) Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages. Int J Hematol 76: 27-34.
34. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, et al. (2009) Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325: 481-483.
35. van Riel D, Rimmelzwaan GF, Van Amerongen G, Osterhaus AD, Kuiken T, (2010) Highly Pathogenic Avian Influenza Virus H7N7 Isolated From a Fatal Human Case Causes Respiratory Disease in Cats, but Does Not Spread Systemically. Am J Pathol 177: 2185-2190.
36. Rimmelzwaan GF, Baars M, Claas EC, Osterhaus AD, (1998) Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods 74: 57-66.
37. van der Fits FL, van der Wel LI, Laman JD, Prens EP, Verschuren MC, (2003) Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2). J Pathol 199: 107-114.